US challenges 'bogus' patents on Ozempic, other drugs in effort to spur competition (1 Viewer)

Users who are viewing this thread

    ABC News: Top Stories

    Guest
    Offline
    abc_news_default_2000x2000_update_4x3t_384.jpg


    The Federal Trade Commission is challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic

    Continue reading...
     

    Create an account or login to comment

    You must be a member in order to leave a comment

    Create account

    Create an account on our community. It's easy!

    Log in

    Already have an account? Log in here.

    Back
    Top Bottom